“America Last” policies continue under the one-week-old Biden Administration that pledged to bring Americans together.
Contrary to his “unity” spiel, Biden’s actions have done everything to divide Americans, from forcing thousands of people out of jobs, to re-funding abortion globally, to now removing access to medication amid an opioid abuse epidemic.
Talk of the coronavirus has swept our news cycle and medical industry to such a high degree that other problems are being ignored as insignificant.
However, just before the pandemic hit in 2020, one of the biggest problems America was facing was opioid abuse.
Addiction Center, an organization that provides resources to individuals struggling with drug abuse, reported there was a 21% increase in opioid-related deaths. “From June 2019 to June 2020, over 83,000 people died from a drug overdose,” they stated.
Unfortunately, the Biden Administration seems so focused on stripping away former President Trump’s legacy that they don’t care how their actions affect the people.
On Thursday, press reports began circulating indicating Biden intends to take presidential action to rescind Trump’s previous order expanding access to a medication called Buprenorphine used to treat Opioid addiction.
According to anonymous sources reported by the Washington Post, Biden’s impending move will reinstate the rule requiring practitioners to obtain the “X-waiver” before prescribing Buprenorphine.
The X-waiver is described by Addiction Center as “a federal license that permits clinicians to prescribe buprenorphine for Opioid addiction treatment.”
Advocates for rescinding the rule say the X-waiver ensures medical experts receive the proper training on prescribing the medication as it can be dangerous if it is over-prescribed. The opposing side says removing the X-waiver will help people get the treatment they need faster.
A draft of Biden’s announcement released by the Post allegedly states, “Unfortunately, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder announced by the Trump administration in its last days had significant legal and clinical concerns.”
Therefore, “The Biden Administration will not issue the Guidelines previously announced.”
This news comes just over two weeks after Trump’s Administration announced the new guidelines “cutting the red tape” to access to the medication.
Biden has promised throughout his campaign that he would work to combat the opioid epidemic; however, his initial actions do not show much promise as he seems to be restricting access to much-needed medications.